Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 4,issue 3  (01-2004)

Period of time： 2004年3期

Publisher： Bentham Science Publishers

Founded in： 2001

Total resources： 18

E-ISSN： 1875-5917|4|3

ISSN： 1568-0088

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 4,issue 3

Menu

Preface [Hot Topic: Endocrinology Meets Molecular Oncology: Beyond Radioactive Iodine (Guest Editor: Robert C. Smallridge)]

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 4,issue 3 , Vol. 4, Iss. 3, 2004-09 , pp. i-ii

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Preface [Hot Topic: Endocrinology Meets Molecular Oncology: Beyond Radioactive Iodine (Guest Editor: Robert C. Smallridge)]

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 4,issue 3 , Vol. 4, Iss. 3, 2004-09 , pp. ii-ii

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

The Sodium-Iodide Symporter

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 4,issue 3 , Vol. 4, Iss. 3, 2004-09 , pp. 167-174

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Redifferentiation Therapy in Advanced Thyroid Cancer

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 4,issue 3 , Vol. 4, Iss. 3, 2004-09 , pp. 175-180

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

AKT: A Potential Target for Thyroid Cancer Therapy

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 4,issue 3 , Vol. 4, Iss. 3, 2004-09 , pp. 181-185

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Molecular Elements of Apoptosis-Regulating Pathways in Follicular Thyroid Cells: Mining for Novel Therapeutic Targets in the Treatment of Thyroid Carcinoma

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 4,issue 3 , Vol. 4, Iss. 3, 2004-09 , pp. 187-198

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Targeting the ERK Pathway: Novel Therapeutics for Thyroid Cancer

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 4,issue 3 , Vol. 4, Iss. 3, 2004-01 , pp. 199-220

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

The PAX8 / PPAR&ggr; Fusion Oncogene as a Potential Therapeutic Target in Follicular Thyroid Carcinoma

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 4,issue 3 , Vol. 4, Iss. 3, 2004-09 , pp. 221-234

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Viral Mediated Gene Therapy for the Management of Metastatic Thyroid Carcinoma

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 4,issue 3 , Vol. 4, Iss. 3, 2004-09 , pp. 235-244

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Dendritic Cell-Based Immunotherapy in Thyroid Malignancies

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 4,issue 3 , Vol. 4, Iss. 3, 2004-09 , pp. 245-251

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Previous 1 2 Next Display item(s) per page Total 11 item(s)